{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T18:11:42Z","timestamp":1725819102600},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.cct.2018.03.008","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T15:10:25Z","timestamp":1521126625000},"page":"45-51","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909)"],"prefix":"10.1016","volume":"68","author":[{"given":"Alexander","family":"Kulik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy M.","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Boronat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas T.","family":"Kouchoukos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ruel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cct.2018.03.008_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0002-9149(94)90198-8","article-title":"Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts","volume":"73","author":"Weintraub","year":"1994","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.cct.2018.03.008_bb0010","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","article-title":"Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention","volume":"97","author":"Motwani","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cct.2018.03.008_bb0015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0735-1097(91)90835-W","article-title":"Fate of venous grafts: the past, the present and the future","volume":"17","author":"Bourassa","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.cct.2018.03.008_bb0020","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","article-title":"Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25\u202fyears","volume":"28","author":"Fitzgibbon","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.cct.2018.03.008_bb0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00001573-199411000-00002","article-title":"The biology of saphenous vein graft occlusion: etiology and strategies for prevention","volume":"9","author":"Bryan","year":"1994","journal-title":"Curr. Opin. Cardiol."},{"issue":"2","key":"10.1016\/j.cct.2018.03.008_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-5273(96)02858-6","article-title":"Clinical outcome in venous coronary artery bypass grafting: a 15-year follow-up study","volume":"58","author":"van Brussel","year":"1997","journal-title":"Int. J. Cardiol."},{"issue":"25","key":"10.1016\/j.cct.2018.03.008_bb0035","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1161\/CIRCULATIONAHA.110.978007","article-title":"Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (cascade) trial","volume":"122","author":"Kulik","year":"2010","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.cct.2018.03.008_bb0040","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa040982","article-title":"A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts","volume":"351","author":"Desai","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.cct.2018.03.008_bb0045","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.294.19.2446","article-title":"Efficacy and safety of edifoligide, an e2f transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: prevent iv: a randomized controlled trial","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cct.2018.03.008_bb0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.87.2.659","article-title":"Aspirin as a therapeutic agent in cardiovascular disease. Special writing group","volume":"87","author":"Fuster","year":"1993","journal-title":"Circulation"},{"issue":"7329","key":"10.1016\/j.cct.2018.03.008_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.cct.2018.03.008_bb0060","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0002-8703(92)90496-I","article-title":"Aspirin use and survival after coronary bypass surgery","volume":"123","author":"Johnson","year":"1992","journal-title":"Am. Heart J."},{"issue":"24","key":"10.1016\/j.cct.2018.03.008_bb0065","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1093\/eurheartj\/ehs367","article-title":"Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (syntax) trial","volume":"33","author":"Farooq","year":"2012","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.cct.2018.03.008_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198207083070201","article-title":"A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency","volume":"307","author":"Chesebro","year":"1982","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cct.2018.03.008_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198401263100401","article-title":"Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations","volume":"310","author":"Chesebro","year":"1984","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cct.2018.03.008_bb0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/1010-7940(93)90155-5","article-title":"Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis","volume":"7","author":"Fremes","year":"1993","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"7427","key":"10.1016\/j.cct.2018.03.008_bb0085","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.327.7427.1309","article-title":"Indirect comparison meta-analysis of aspirin therapy after coronary surgery","volume":"327","author":"Lim","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.cct.2018.03.008_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0025-7125(05)70212-1","article-title":"Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease","volume":"84","author":"Bhatt","year":"2000","journal-title":"Med. Clin. North Am."},{"issue":"12","key":"10.1016\/j.cct.2018.03.008_bb0095","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","article-title":"Development of aspirin resistance in persons with previous ischemic stroke","volume":"25","author":"Helgason","year":"1994","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.cct.2018.03.008_bb0100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.cct.2018.03.008_bb0105","first-page":"221","article-title":"Individual variation in the effects of asa on platelet function: implications for the use of asa clinically","volume":"11","author":"Buchanan","year":"1995","journal-title":"Can. J. Cardiol."},{"issue":"7","key":"10.1016\/j.cct.2018.03.008_bb0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without st-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.cct.2018.03.008_bb0115","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.cct.2018.03.008_bb0120","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-st-elevation acute coronary syndrome: the clopidogrel in unstable angina to prevent recurrent ischemic events (cure) trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cct.2018.03.008_bb0125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.amjcard.2004.05.026","article-title":"Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention","volume":"94","author":"Saw","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.cct.2018.03.008_bb0130","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jtcvs.2009.07.027","article-title":"Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting","volume":"138","author":"Kim","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"10","key":"10.1016\/j.cct.2018.03.008_bb0135","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jacc.2010.09.069","article-title":"Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction","volume":"57","author":"Sorensen","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.cct.2018.03.008_bb0140","first-page":"1417","article-title":"Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients","volume":"82","author":"David","year":"1999","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.cct.2018.03.008_bb0145","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.ahj.2010.07.035","article-title":"Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting study","volume":"160","author":"Sun","year":"2010","journal-title":"Am. Heart J."},{"issue":"20","key":"10.1016\/j.cct.2018.03.008_bb0150","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2010.03.104","article-title":"Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial","volume":"56","author":"Gao","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cct.2018.03.008_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.athoracsur.2013.08.058","article-title":"Effect of clopidogrel use post coronary artery bypass surgery on graft patency","volume":"97","author":"Ebrahimi","year":"2014","journal-title":"Ann. Thorac. Surg."},{"issue":"11","key":"10.1016\/j.cct.2018.03.008_bb0160","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cct.2018.03.008_bb0165","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the plato (platelet inhibition and patient outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.cct.2018.03.008_bb0170","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cct.2018.03.008_bb0175","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/HCO.0000000000000331","article-title":"Secondary prevention after coronary artery bypass graft surgery: a primer","volume":"31","author":"Kulik","year":"2016","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.cct.2018.03.008_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ahj.2016.05.017","volume":"179","author":"de Waha","year":"2016","journal-title":"Am. Heart J."},{"issue":"10","key":"10.1016\/j.cct.2018.03.008_bb0185","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/heartjnl-2015-308691","article-title":"Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery","volume":"102","author":"Saw","year":"2016","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.cct.2018.03.008_bb0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/14740330902797081","article-title":"Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy","volume":"8","author":"Kulik","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"issue":"10","key":"10.1016\/j.cct.2018.03.008_bb0195","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the american heart association","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.cct.2018.03.008_bb0200","doi-asserted-by":"crossref","first-page":"e652","DOI":"10.1161\/CIR.0b013e31823c074e","article-title":"accf\/aha guideline for coronary artery bypass graft surgery: a report of the american college of cardiology foundation\/american heart association task force on practice guidelines","volume":"124","author":"Hillis","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cct.2018.03.008_bb0205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.athoracsur.2006.08.018","article-title":"Multi-detector computed tomography in coronary artery bypass graft assessment: a meta-analysis","volume":"83","author":"Jones","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.cct.2018.03.008_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1468-6708-6-15","article-title":"The clopidogrel after surgery for coronary artery disease (cascade) randomized controlled trial: Clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [nct00228423]","volume":"6","author":"Kulik","year":"2005","journal-title":"Curr. Control Trials Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.cct.2018.03.008_bb0215","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u20142014 update: a report from the American heart association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.cct.2018.03.008_bb0220","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"Aha\/accf secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American heart association and American college of cardiology foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714417306730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714417306730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T04:55:05Z","timestamp":1535000105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714417306730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":44,"alternative-id":["S1551714417306730"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2018.03.008","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909)","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2018.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}